{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:32:23Z","timestamp":1792758743925,"version":"4.5.0"},"reference-count":177,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UI\/BD\/150865\/2021"],"award-info":[{"award-number":["UI\/BD\/150865\/2021"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.bioorg.2023.106600","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T21:17:04Z","timestamp":1683753424000},"page":"106600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"special_numbering":"C","title":["Synthetic and natural guanidine derivatives as antitumor and antimicrobial agents: A review"],"prefix":"10.1016","volume":"138","author":[{"given":"Ana R.","family":"Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla L.","family":"Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana S.","family":"Pires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisi\u00e1rio J.","family":"Tavares-da-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda M.F.","family":"Roleira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2023.106600_b0005","series-title":"Guanidines: Historical, Biological, Biochemical, and Clinical Aspects of the Naturally Occurring Guanidino Compounds","author":"Mori","year":"1985"},{"key":"10.1016\/j.bioorg.2023.106600_b0010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0079-6468(08)70378-3","article-title":"Amidines and guanidines in medicinal chemistry","volume":"30","author":"Greenhill","year":"1993","journal-title":"Prog. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113293","article-title":"Antimicrobial drugs bearing guanidine moieties: A review","volume":"216","author":"Kim","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/poc.578","article-title":"Consequences of proton transfer in guanidine","volume":"16","author":"Raczy\u0144ska","year":"2003","journal-title":"J. Phys. Org. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0025","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1517\/13543770903216675","article-title":"Biological activities of guanidine compounds","volume":"19","author":"Saczewski","year":"2009","journal-title":"Expert Opin. Ther. Pat."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106600_b0030","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1039\/D0NP00051E","article-title":"The chemistry and biology of guanidine secondary metabolites","volume":"38","author":"Berlinck","year":"2021","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bioorg.2023.106600_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/7081_2015_174","article-title":"Synthesis of guanidines and some of their biological applications","volume":"50","author":"Shaw","year":"2015","journal-title":"Top. Heterocycl. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0040","doi-asserted-by":"crossref","first-page":"9302","DOI":"10.1021\/acs.jpcb.9b06130","article-title":"Role of guanidinium-carboxylate ion interaction in enzyme inhibition with implications for drug design","volume":"123","author":"Muttathukattil","year":"2019","journal-title":"J. Phys. Chem. B"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106600_b0045","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1517\/17460441.2013.857308","article-title":"Novel approaches to screening guanidine derivatives","volume":"9","author":"Rauf","year":"2014","journal-title":"Expert. Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2023.106600_b0050","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1039\/C4CS00013G","article-title":"Guanidines: from classical approaches to efficient catalytic syntheses","volume":"43","author":"Alonso-Moreno","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioorg.2023.106600_b0055","first-page":"200","article-title":"Guanidine: a simple molecule with great potential: from catalysts to biocides and molecular glues","volume":"3","author":"Drozdov","year":"2021","journal-title":"Ineos Open."},{"key":"10.1016\/j.bioorg.2023.106600_b0060","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2174\/1385272821666170127153759","article-title":"Recent progress in chiral guanidine-catalyzed Michael reactions","volume":"21","author":"Yuan","year":"2017","journal-title":"Curr. Org. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106600_b0065","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1021\/ed049p100","article-title":"Guanidine, trimethylenemethane, and \u201cY-delocalization.\u201d Can acyclic compounds have \u201caromatic\u201d stability?","volume":"49","author":"Gund","year":"1972","journal-title":"J. Chem. Educ."},{"key":"10.1016\/j.bioorg.2023.106600_b0070","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1002\/chem.200900508","article-title":"Solid-State structure of free base guanidine achieved at last","volume":"15","author":"Yamada","year":"2009","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.bioorg.2023.106600_b0075","series-title":"Superbases for Organic Synthesis","author":"Ishikawa","year":"2009"},{"key":"10.1016\/j.bioorg.2023.106600_b0080","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1055\/s-2006-926325","article-title":"Guanidines in organic synthesis","volume":"2006","author":"Ishikawa","year":"2006","journal-title":"Synthesis (Stuttg)"},{"key":"10.1016\/j.bioorg.2023.106600_b0085","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/asia.200800361","article-title":"Chiral guanidine catalyzed enantioselective reactions","volume":"4","author":"Leow","year":"2009","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.bioorg.2023.106600_b0090","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1055\/s-0032-1318154","article-title":"Guanidine organocatalysis","volume":"45","author":"Selig","year":"2013","journal-title":"Synthesis (Stuttg)."},{"key":"10.1016\/j.bioorg.2023.106600_b0095","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1248\/cpb.58.1555","article-title":"Guanidine chemistry","volume":"58","author":"Ishikawa","year":"2010","journal-title":"Chem. Pharm. Bull. (Tokyo)."},{"key":"10.1016\/j.bioorg.2023.106600_b0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bioorg.2015.01.006","article-title":"Guanidines from \u201ctoxic substances\u201d to compounds with multiple biological applications - Detailed outlook on synthetic procedures employed for the synthesis of guanidines","volume":"59","author":"Tahir","year":"2015","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/157019306778742841","article-title":"Synthesis of guanidines in solution","volume":"3","author":"Suhs","year":"2006","journal-title":"Mini Rev Org Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0110","doi-asserted-by":"crossref","DOI":"10.1002\/chin.200530277","article-title":"Recent developments in guanylating agents","volume":"36","author":"Katritzky","year":"2005","journal-title":"ChemInform"},{"key":"10.1016\/j.bioorg.2023.106600_b0115","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1021\/jo0265535","article-title":"Phase-transfer-catalyzed alkylation of guanidines by alkyl halides under biphasic conditions: A convenient protocol for the synthesis of highly functionalized guanidines","volume":"68","author":"Powell","year":"2003","journal-title":"J. Org. Chem."},{"issue":"39","key":"10.1016\/j.bioorg.2023.106600_b0120","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1016\/j.tetlet.2006.07.138","article-title":"The first bismuth(III)-catalyzed guanylation of thioureas","volume":"47","author":"Cunha","year":"2006","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2023.106600_b0125","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1016\/S0040-4020(97)00193-2","article-title":"The HgCl2-promoted guanylation reaction: The scope and limitations","volume":"53","author":"Levallet","year":"1997","journal-title":"Tetrahedron"},{"issue":"34","key":"10.1016\/j.bioorg.2023.106600_b0130","doi-asserted-by":"crossref","first-page":"150970","DOI":"10.1016\/j.tetlet.2019.150970","article-title":"Synthesis of guanidines via the I2 mediated desulfurization of N, N\u2032-di-Boc-thiourea","volume":"60","author":"Rong","year":"2019","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2023.106600_b0135","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1055\/s-0035-1562478","article-title":"Facile guanidine formation under mild acidic conditions","volume":"27","author":"Takeuchi","year":"2016","journal-title":"Synlett"},{"key":"10.1016\/j.bioorg.2023.106600_b0140","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1021\/jo00360a040","article-title":"A convenient synthesis of guanidines from thioureas","volume":"51","author":"Maryanoff","year":"1986","journal-title":"J. Org. Chem."},{"issue":"29","key":"10.1016\/j.bioorg.2023.106600_b0145","doi-asserted-by":"crossref","first-page":"6868","DOI":"10.1021\/ja960667e","article-title":"Synthesis of 11 C-labeled guanidines in supercritical ammonia","volume":"118","author":"Jacobson","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2023.106600_b0150","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1055\/s-0033-1341080","article-title":"Direct guanylation of amino groups by cyanamide in water: Catalytic generation and activation of unsubstituted carbodiimide by scandium(III) triflate","volume":"25","author":"Tsubokura","year":"2014","journal-title":"Synlett"},{"key":"10.1016\/j.bioorg.2023.106600_b0155","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/cjoc.201300302","article-title":"Synthesis of guanidines from amines and carbodiimides catalyzed by mono-indenyl-ligated rare earth metal bis(silylamide) complexes","volume":"31","author":"Chen","year":"2013","journal-title":"Chin. J. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0160","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1039\/D0CC03270K","article-title":"Transformation of carbodiimides to guanidine derivatives facilitated by gallylenes","volume":"56","author":"Dodonov","year":"2020","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2023.106600_b0165","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1021\/jo00034a059","article-title":"1H-pyrazole-1-carboxamidine hydrochloride: an attractive reagent for guanylation of amines and its application to peptide synthesis","volume":"57","author":"Bernatowicz","year":"1992","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0170","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1016\/j.tet.2018.06.057","article-title":"Ultrasound-assisted synthesis of substituted guanidines using 1H-pyrazole-1-carboxamidine and S-methylisothiouronium sulfate under solvent-free conditions","volume":"74","author":"Fujita","year":"2018","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2023.106600_b0175","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1021\/jo980425s","article-title":"Diprotected triflylguanidines: a new class of guanidinylation reagents","volume":"63","author":"Feichtinger","year":"1998","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0180","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1021\/ol010191q","article-title":"N,N\u2032-Di-tert-butoxycarbonyl-1H-benzotriazole-1 -carboxamidine derivatives are highly reactive guanidinylating reagents","volume":"3","author":"Musiol","year":"2001","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2023.106600_b0185","doi-asserted-by":"crossref","first-page":"8223","DOI":"10.1039\/c3dt50477h","article-title":"Asymmetric niobium guanidinates as intermediates in the catalytic guanylation of amines","volume":"42","author":"Elorriaga","year":"2013","journal-title":"Dalton Trans."},{"key":"10.1016\/j.bioorg.2023.106600_b0190","doi-asserted-by":"crossref","first-page":"8100","DOI":"10.1021\/ja035716j","article-title":"Catalytic construction and reconstruction of guanidines: Ti-mediated guanylation of amines and transamination of guanidines","volume":"125","author":"Ong","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2023.106600_b0195","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.1039\/c0dt00064g","article-title":"Oxo- and imido-alkoxide vanadium complexes as precatalysts for the guanylation of aromatic amines","volume":"39","author":"Romero-Fern\u00e1ndez","year":"2010","journal-title":"Dalton Trans."},{"key":"10.1016\/j.bioorg.2023.106600_b0200","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1021\/om201192w","article-title":"New alkylimido niobium complexes supported by guanidinate ligands: Synthesis, characterization, and migratory insertion reactions","volume":"31","author":"Elorriaga","year":"2012","journal-title":"Organometallics"},{"key":"10.1016\/j.bioorg.2023.106600_b0205","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1002\/chem.200601383","article-title":"Catalytic addition of amine N-H bonds to carbodiimides by half-sandwich rare-earth metal complexes: efficient synthesis of substituted guanidines through amine protonolysis of rare-earth metal guanidinates","volume":"13","author":"Zhang","year":"2007","journal-title":"Chemistry"},{"key":"10.1016\/j.bioorg.2023.106600_b0210","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1021\/ol201752e","article-title":"Ti-amide catalyzed synthesis of cyclic guanidines from di-\/triamines and carbodiimides","volume":"13","author":"Shen","year":"2011","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2023.106600_b0215","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1021\/jo0709089","article-title":"Highly atom efficient guanylation of both aromatic and secondary amines catalyzed by simple lanthanide amides","volume":"72","author":"Li","year":"2007","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0220","doi-asserted-by":"crossref","unstructured":"S. Zhou, S. Wang, G. Yang, Q. Li, L. Zhang, Z. Yao, Z. Zhou, H. bin Song, Synthesis, structure, and diverse catalytic activities of [ethylenebis(indenyl)]lanthanide(III) amides on N - H and C - H addition to carbodiimides and \u03b5-caprolactone polymerization, Organometallics. 26 (2007) 3755\u20133761. https:\/\/doi.org\/10.1021\/OM070234S\/SUPPL_FILE\/OM070234SSI20070311_060034.PDF.","DOI":"10.1021\/om070234s"},{"key":"10.1016\/j.bioorg.2023.106600_b0225","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1016\/j.ica.2008.12.030","article-title":"Efficient guanylation of aromatic and heterocyclic amines catalyzed by cyclopentadienyl-free rare earth metal amides","volume":"362","author":"Wu","year":"2009","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.bioorg.2023.106600_b0230","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1021\/jo900903t","article-title":"Ytterbium triflate: A highly active catalyst for addition of amines to carbodiimides to N, N\u2032, N\u2033-trisubstituted guanidines","volume":"74","author":"Zhu","year":"2009","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0235","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1021\/om060539r","article-title":"Facile and atom-efficient amidolithium-catalyzed C-C and C-N formation for the construction of substituted guanidines and propiolamidines","volume":"25","author":"Ong","year":"2006","journal-title":"Organometallics"},{"key":"10.1016\/j.bioorg.2023.106600_b0240","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1021\/om801035t","article-title":"Alkyl aluminum-catalyzed addition of amines to carbodiimides: A highly efficient route to substituted guanidines","volume":"28","author":"Zhang","year":"2009","journal-title":"Organometallics"},{"key":"10.1016\/j.bioorg.2023.106600_b0245","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1016\/j.tetlet.2012.07.065","article-title":"First iron-catalyzed guanylation of amines: a simple and highly efficient protocol to guanidines","volume":"53","author":"Pottabathula","year":"2012","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2023.106600_b0250","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1517\/13543776.2013.788645","article-title":"Biological activities of guanidine compounds, 2008\u20132012 update","volume":"23","author":"Saczewski","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2023.106600_b0255","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejmech.2015.10.022","article-title":"The synthesis of indolo[2,3-b]quinoline derivatives with a guanidine group: Highly selective cytotoxic agents","volume":"105","author":"Sidoryk","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0260","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1007\/s00044-017-2028-1","article-title":"An efficient synthesis of indolo[2,3-b]quinoline guanidine derivatives with their in vitro and in vivo study","volume":"26","author":"Sidoryk","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2023.106600_b0265","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1021\/jm7013088","article-title":"New bis(2-aminoimidazoline) and bisguanidine DNA minor groove binders with potent in vivo antitrypanosomal and antiplasmodial activity","volume":"51","author":"Rodr\u00edguez","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0270","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.1039\/c0ob00428f","article-title":"Understanding the DNA binding of novel non-symmetrical guanidinium\/2- aminoimidazolinium derivatives","volume":"8","author":"Nagle","year":"2010","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0275","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1021\/jm301358s","article-title":"Aromatic bis-N-hydroxyguanidinium Derivatives: synthesis, biophysical, and biochemical evaluations","volume":"56","author":"Kahved\u017ei\u0107","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0280","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1021\/om400446y","article-title":"A new age for iron: Antitumoral ferrocenes","volume":"32","author":"Braga","year":"2013","journal-title":"Organometallics"},{"key":"10.1016\/j.bioorg.2023.106600_b0285","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1021\/acs.organomet.5b00751","article-title":"Catalytically generated ferrocene-containing guanidines as efficient precursors for new redox-active heterometallic platinum(II) complexes with anticancer activity","volume":"34","author":"Nieto","year":"2015","journal-title":"Organometallics"},{"key":"10.1016\/j.bioorg.2023.106600_b0290","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1021\/acs.organomet.8b00702","article-title":"Coordination behavior of N, N\u2032, N\u2033-trisubstituted guanidine ligands in their Ru-arene complexes: synthetic, DNA\/protein binding, and cytotoxic studies","volume":"38","author":"Jeyalakshmi","year":"2019","journal-title":"Organometallics"},{"key":"10.1016\/j.bioorg.2023.106600_b0295","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.ccr.2013.01.034","article-title":"Bioactive iridium and rhodium complexes as therapeutic agents","volume":"257","author":"Leung","year":"2013","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.bioorg.2023.106600_b0300","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ejmech.2017.06.038","article-title":"Cyclometalated iridium(III)-guanidinium complexes as mitochondria-targeted anticancer agents","volume":"138","author":"Song","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0305","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jinorgbio.2016.09.004","article-title":"Ru(II) complexes bearing guanidinium ligands as potent anticancer agents","volume":"164","author":"Chen","year":"2016","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bioorg.2023.106600_b0310","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nature01148","article-title":"Rho GTPases in cancer cell biology","volume":"420","author":"Etienne-Manneville","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2023.106600_b0315","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10585-007-9119-1","article-title":"Rho GTPases: Functions and association with cancer","volume":"24","author":"Ellenbroek","year":"2007","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.bioorg.2023.106600_b0320","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1038\/sj.onc.1203621","article-title":"Rac1 in human breast cancer: Overexpression, mutation analysis, and characterization of a new isoform, Rac1b","volume":"19","author":"Schnelzer","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2023.106600_b0325","doi-asserted-by":"crossref","first-page":"840","DOI":"10.2174\/18715206113136660334","article-title":"Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines","volume":"14","author":"Cardama","year":"2014","journal-title":"Anticancer Agents Med Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0330","first-page":"2021","article-title":"Proapoptotic and antiinvasive activity of Rac1 small molecule inhibitors on malignant glioma cells","volume":"7","author":"Cardama","year":"2014","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.bioorg.2023.106600_b0335","doi-asserted-by":"crossref","first-page":"98509","DOI":"10.18632\/oncotarget.21533","article-title":"Pharmacological Rac1 inhibitors with selective apoptotic activity in human acute leukemic cell lines","volume":"8","author":"Cabrera","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2023.106600_b0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cmdc.202000763","article-title":"Development of a new and improved guanidine-based Rac1 inhibitor with in vivo activity against non-small cell lung cancer","volume":"16","author":"Ciarlantini","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2023.106600_b0345","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nrm3598","article-title":"The mechanisms of Hedgehog signalling and its roles in development and disease","volume":"14","author":"Briscoe","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106600_b0350","doi-asserted-by":"crossref","first-page":"e0149919","DOI":"10.1371\/journal.pone.0149919","article-title":"Novel acylguanidine derivatives targeting smoothened induce antiproliferative and pro-apoptotic effects in chronic myeloid leukemia cells","volume":"11","author":"Chiarenza","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2023.106600_b0355","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1021\/jm2013369","article-title":"Acylthiourea, acylurea, and acylguanidine derivatives with potent Hedgehog inhibiting activity","volume":"55","author":"Solinas","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0360","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1096\/fj.14-267849","article-title":"MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor","volume":"29","author":"Hoch","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.bioorg.2023.106600_b0365","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-017-0142-0","article-title":"Targeted inhibition of Hedgehog-GLI signaling by novel acylguanidine derivatives inhibits melanoma cell growth by inducing replication stress and mitotic catastrophe","volume":"9","author":"Pietrobono","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2023.106600_b0370","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ejmech.2018.07.053","article-title":"Hedgehog pathway inhibitors of the acylthiourea and acylguanidine class show antitumor activity on colon cancer in vitro and in vivo","volume":"157","author":"Vesci","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0375","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ejmech.2017.06.059","article-title":"Novel 2-(2-alkylthiobenzenesulfonyl)-3-(phenylprop-2-ynylideneamino)guanidine derivatives as potent anticancer agents \u2013 Synthesis, molecular structure, QSAR studies and metabolic stability","volume":"138","author":"Pogorzelska","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0380","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/cmdc.202000218","article-title":"Sulfonylguanidine derivatives as potential antimelanoma agents","volume":"15","author":"Baladi","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2023.106600_b0385","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev-cellbio-101011-155711","article-title":"Microtubules in cell migration","volume":"29","author":"Etienne-Manneville","year":"2013","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.bioorg.2023.106600_b0390","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1002\/cmdc.202000544","article-title":"\u03b1\u2013\u03c9 Alkenyl-bis-S-guanidine thiourea dihydrobromide affects HeLa cell growth hampering tubulin polymerization","volume":"15","author":"Ceramella","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2023.106600_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110242","article-title":"Novel indole-guanidine hybrids as potential anticancer agents: Design, synthesis and biological evaluation","volume":"368","author":"Li","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2023.106600_b0400","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.3390\/ijms24054436","article-title":"Synthesis of 3-(2-Alkylthio-4-chloro-5-methylbenzenesulfonyl)-2-(1-phenyl-3-arylprop-2-enylideneamino)guanidine derivatives with pro-apoptotic activity against cancer cells","volume":"24","author":"Pogorzelska","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2023.106600_b0405","doi-asserted-by":"crossref","first-page":"PMC.S14459","DOI":"10.4137\/PMC.S14459","article-title":"Antibiotics and bacterial resistance in the 21st century","volume":"6","author":"Fair","year":"2014","journal-title":"Perspect. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0410","unstructured":"IACG, No Time To Wait: Securing the Future From Drug-Resistant Infections Report To the Secretary-General of the United Nations, World Health Organisation. (2019) 1\u201328."},{"key":"10.1016\/j.bioorg.2023.106600_b0415","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1016\/j.bmcl.2014.09.081","article-title":"Synthesis of linear and cyclic guazatine derivatives endowed with antibacterial activity","volume":"24","author":"Maccari","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.106600_b0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-08749-6","article-title":"Identification, synthesis and biological activity of alkyl-guanidine oligomers as potent antibacterial agents","volume":"7","author":"Zamperini","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2023.106600_b0425","doi-asserted-by":"crossref","first-page":"9162","DOI":"10.1021\/acs.jmedchem.8b00619","article-title":"Alkyl-guanidine compounds as potent broad-spectrum antibacterial agents: chemical library extension and biological characterization","volume":"61","author":"Pasero","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0430","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ejmech.2014.07.109","article-title":"Ferrocene-based guanidine derivatives: In vitro antimicrobial, DNA binding and docking supported urease inhibition studies","volume":"85","author":"Gul","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0435","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1007\/s11164-016-2454-6","article-title":"Guanidinyl benzothiazole derivatives: Synthesis and structure activity relationship studies of a novel series of potential antimicrobial and antioxidants","volume":"42","author":"Bhat","year":"2016","journal-title":"Res. Chem. Intermed."},{"key":"10.1016\/j.bioorg.2023.106600_b0440","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.2147\/IDR.S234509","article-title":"In vitro antibacterial activity of isopropoxy benzene guanidine against multidrug-resistant Enterococci","volume":"12","author":"Zhang","year":"2019","journal-title":"Infect Drug Resist."},{"key":"10.1016\/j.bioorg.2023.106600_b0445","unstructured":"D. Rejman, Lipophosphonoxins, method of their preparation and use, EP Patent 0879946A2. 1 (2012) 1\u201331."},{"key":"10.1016\/j.bioorg.2023.106600_b0450","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.1021\/acs.jmedchem.7b00355","article-title":"Lipophosphonoxins II: Design, synthesis, and properties of novel broad spectrum antibacterial agents","volume":"60","author":"Seydlov\u00e1","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0455","doi-asserted-by":"crossref","unstructured":"A.C. Society, Cancer Facts & Figures 2020, Sci Rep. 8 (2020). https:\/\/doi.org\/10.1038\/s41598-018-28671-9.","DOI":"10.1038\/s41598-018-28671-9"},{"key":"10.1016\/j.bioorg.2023.106600_b0460","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1021\/jm501285x","article-title":"Amino acid modified xanthone derivatives: Novel, highly promising membrane-active antimicrobials for multidrug-resistant gram-positive bacterial infections","volume":"58","author":"Koh","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0465","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1021\/acs.jmedchem.6b01403","article-title":"Symmetrically Substituted xanthone amphiphiles combat Gram-positive bacterial resistance with enhanced membrane selectivity","volume":"60","author":"Lin","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0470","doi-asserted-by":"crossref","first-page":"11948","DOI":"10.1039\/C7CC07285F","article-title":"Novel bis-cyclic guanidines as potent membrane-active antibacterial agents with therapeutic potential","volume":"53","author":"Teng","year":"2017","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2023.106600_b0475","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1021\/acs.jmedchem.7b00380","article-title":"Semisynthetic flavone-derived antimicrobials with therapeutic potential against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"60","author":"Lin","year":"2017","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106600_b0480","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.amjmed.2006.03.014","article-title":"Resistance in nonfermenting Gram-negative bacteria: multidrug resistance to the maximum","volume":"119","author":"McGowan","year":"2006","journal-title":"Am. J. Med."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106600_b0485","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3390\/molecules23051158","article-title":"Novel guanidine compound against multidrug-resistant cystic fibrosis-associated bacterial species","volume":"23","author":"Saeed","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2023.106600_b0490","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3390\/antibiotics11081115","article-title":"Development of dicationic bisguanidine-arylfuran derivatives as potent agents against Gram-negative bacteria","volume":"11","author":"Bourgard","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.bioorg.2023.106600_b0495","unstructured":"World Health Organization, Global Tuberculosis Report 2022, Geneva, 2022. http:\/\/apps.who.int\/bookorders."},{"key":"10.1016\/j.bioorg.2023.106600_b0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133899","article-title":"Synthesis, characterization, anti-tuberculosis activity and molecular modeling studies of thiourea derivatives bearing aminoguanidine moiety","volume":"1270","author":"Tapera","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2023.106600_b0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114734","article-title":"Design, synthesis, and biological evaluation of tetrahydroquinoline amphiphiles as membrane-targeting antimicrobials against pathogenic bacteria and fungi","volume":"243","author":"Liu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0510","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bioorg.2023.106600_b0515","doi-asserted-by":"crossref","first-page":"10135","DOI":"10.1021\/acs.jmedchem.7b01348","article-title":"Semisynthesis and biological evaluation of xanthone amphiphilics as selective, highly potent antifungal agents to combat fungal resistance","volume":"60","author":"Lin","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0520","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1021\/bk-2015-1204.ch013","article-title":"Succinate dehydrogenase: An ideal target for fungicide discovery","volume":"1204","author":"Xiong","year":"2015","journal-title":"ACS Symp. Ser."},{"key":"10.1016\/j.bioorg.2023.106600_b0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115846","article-title":"Design, synthesis biological activity, and docking of novel fluopyram derivatives containing guanidine group","volume":"29","author":"Liang","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0530","doi-asserted-by":"crossref","unstructured":"R. Espirito Santo, M. Machado, J. Santos, E. Gonzalez, C. Chin, Use of Guanidine Compounds in the Treatment of Neglected Tropical Diseases, 2014. https:\/\/doi.org\/10.2174\/138527281820141028104429.","DOI":"10.2174\/138527281820141028104429"},{"key":"10.1016\/j.bioorg.2023.106600_b0535","doi-asserted-by":"crossref","unstructured":"R.R. Tidwell, D.W. Boykin, Dicationic DNA Minor Groove Binders as Antimicrobial Agents, 2004. https:\/\/doi.org\/10.1002\/3527601783.ch16.","DOI":"10.1002\/3527601783.ch16"},{"key":"10.1016\/j.bioorg.2023.106600_b0540","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1021\/jm060295c","article-title":"DNA binding affinity of bisguanidine and bis(2-aminoimidazoline) derivatives with in vivo antitrypanosomal activity","volume":"49","author":"Dardonville","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0545","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.1016\/j.ejmech.2011.09.047","article-title":"Molecular modeling study and synthesis of novel dicationic flexible triaryl guanidines and imidamides as antiprotozoal agents","volume":"46","author":"Arafa","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0550","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1021\/jm301614w","article-title":"Aminoalkyl derivatives of guanidine diaromatic minor groove binders with antiprotozoal activity","volume":"56","author":"McKeever","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0555","unstructured":"World Health Organization, Leishmaniasis, WHO Site. (2020). https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/leishmaniasis."},{"key":"10.1016\/j.bioorg.2023.106600_b0560","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejmech.2019.03.032","article-title":"N\u2032 N\u2033-trisubstituted guanidines: Synthesis, characterization and evaluation of their leishmanicidal activity","volume":"171","author":"do Esp\u00edrito Santo","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0565","doi-asserted-by":"crossref","unstructured":"F.S. Almeida, V.P. Moreira, S. Silva, L. Lima Cardoso, P. Henrique De Sousa Palmeira, L. Henrique, A. Cavalcante-Silva, D.A.M. De Ara\u00fajo, I.P.G. Do Amaral, E. Ren\u00e9 P\u00e9rez Gonz\u00e1lez, T.S.L. Keesen, Leishmanicidal activity of guanidine derivatives against leishmania infantum, tropical medicine and infectious disease 2023, Vol. 8, Page 141. 8 (2023) 141. https:\/\/doi.org\/10.3390\/TROPICALMED8030141.","DOI":"10.3390\/tropicalmed8030141"},{"issue":"9","key":"10.1016\/j.bioorg.2023.106600_b0570","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1021\/acs.jnatprod.6b00256","article-title":"Analogues of marine guanidine alkaloids are invitro effective against trypanosoma cruzi and selectively eliminate Leishmania (L.) infantum intracellular amastigotes","volume":"79","author":"Martins","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2023.106600_b0575","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.gene.2004.05.007","article-title":"Cellular control of gene expression by T-type cyclin\/CDK9 complexes","volume":"337","author":"Garriga","year":"2004","journal-title":"Gene"},{"key":"10.1016\/j.bioorg.2023.106600_b0580","first-page":"738","article-title":"Design, synthesis and biological evaluation of substituted guanidine indole derivatives as potential inhibitors of HIV-1 Tat-TAR interaction","volume":"10","author":"Wang","year":"2014","journal-title":"Med. Chem. (Los Angeles)"},{"key":"10.1016\/j.bioorg.2023.106600_b0585","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.cell.2009.01.029","article-title":"The influenza virus enigma","volume":"136","author":"Salomon","year":"2009","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.bioorg.2023.106600_b0590","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1021\/jm401977j","article-title":"Oseltamivir analogues bearing N-substituted guanidines as potent neuraminidase inhibitors","volume":"57","author":"Mooney","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0595","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/srep02871","article-title":"Structural basis for a class of nanomolar influenza A neuraminidase inhibitors","volume":"3","author":"Kerry","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2023.106600_b0600","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/cbic.201300606","article-title":"Macromolecular uptake of alkyl-chain-modified guanidinoglycoside molecular transporters","volume":"15","author":"Inoue","year":"2014","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bioorg.2023.106600_b0605","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1111\/bph.14918","article-title":"Guanidine modifications enhance the anti-herpes simplex virus activity of (E, E)-4,6-bis(styryl)-pyrimidine derivatives in vitro and in vivo","volume":"177","author":"Wang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2023.106600_b0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules24213913","article-title":"Guanidine-containing polyhydroxyl macrolides: chemistry, biology, and structure-activity relationship","volume":"24","author":"Song","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2023.106600_b0615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/md15100324","article-title":"Recent advances in the isolation, synthesis and biological activity of marine guanidine alkaloids","volume":"15","author":"Liu","year":"2017","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.bioorg.2023.106600_b0620","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1016\/j.bmc.2017.03.015","article-title":"Structure, synthesis and biological properties of the pentacyclic guanidinium alkaloids","volume":"25","author":"Shi","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0625","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.3390\/md13106336","article-title":"Marine-based nutraceuticals: An innovative trend in the food and supplement industries","volume":"13","author":"Suleria","year":"2015","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.bioorg.2023.106600_b0630","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd4510","article-title":"The re-emergence of natural products for drug discovery in the genomics era","volume":"14","author":"Harvey","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2023.106600_b0635","first-page":"3","article-title":"Natural products in cancer therapy: past, present and future","volume":"2","author":"Huang","year":"2021","journal-title":"Nat. Prod. Bioprospect."},{"key":"10.1016\/j.bioorg.2023.106600_b0640","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/cbdv.201000161","article-title":"Guanidine alkaloids from Monanchora arbuscula: Chemistry and antitumor potential","volume":"8","author":"Ferreira","year":"2011","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.bioorg.2023.106600_b0645","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1021\/np200452m","article-title":"Monanchocidins B-E: Polycyclic guanidine alkaloids with potent antileukemic activities from the sponge Monanchora pulchra","volume":"74","author":"Makarieva","year":"2011","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2023.106600_b0650","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1016\/j.tetlet.2012.05.162","article-title":"Monanchomycalins A and B, unusual guanidine alkaloids from the sponge Monanchora pulchra","volume":"53","author":"Makarieva","year":"2012","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2023.106600_b0655","doi-asserted-by":"crossref","first-page":"17328","DOI":"10.18632\/oncotarget.4175","article-title":"Marine alkaloid Monanchocidin a overcomes drug resistance by induction of autophagy and lysosomal membrane permeabilization","volume":"6","author":"Dyshlovoy","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.bioorg.2023.106600_b0660","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/md16020053","article-title":"Crambescidin 800, isolated from the marine sponge monanchora viridis, induces cell cycle arrest and apoptosis in triple-negative breast cancer cells","volume":"16","author":"Shrestha","year":"2018","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.bioorg.2023.106600_b0665","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1021\/acs.jnatprod.6b00168","article-title":"Cytotoxic guanidine alkaloids from a French Polynesian Monanchora n. sp. Sponge","volume":"79","author":"El-Demerdash","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2023.106600_b0670","doi-asserted-by":"crossref","first-page":"83071","DOI":"10.18632\/oncotarget.13068","article-title":"Marine guanidine alkaloids crambescidins inhibit tumor growth and activate intrinsic apoptotic signaling inducing tumor regression in a colorectal carcinoma zebrafish xenograft model","volume":"7","author":"Roel","year":"2016","journal-title":"Oncotarget"},{"issue":"13","key":"10.1016\/j.bioorg.2023.106600_b0675","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1080\/14786419.2017.1385011","article-title":"Unguiculins A-C: cytotoxic bis-guanidine alkaloids from the French Polynesian sponge, Monanchora n. sp.","volume":"32","author":"El-Demerdash","year":"2018","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.bioorg.2023.106600_b0680","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1080\/14786419.2017.1419231","article-title":"Monanchoxymycalin C with anticancer properties, new analogue of crambescidin 800 from the marine sponge Monanchora pulchra","volume":"33","author":"Shubina","year":"2019","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.bioorg.2023.106600_b0685","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/med.21423","article-title":"Marine mollusk-derived agents with antiproliferative activity as promising anticancer agents to overcome chemotherapy resistance","volume":"37","author":"Ciavatta","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2023.106600_b0690","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1021\/acs.jnatprod.6b00941","article-title":"Marine terpenoid diacylguanidines: structure, synthesis, and biological evaluation of naturally occurring actinofide and synthetic analogues","volume":"80","author":"Carbone","year":"2017","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2023.106600_b0695","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1021\/acs.orglett.8b01069","article-title":"KB343, a cyclic tris-guanidine alkaloid from palauan zoantharian Epizoanthus illoricatus","volume":"20","author":"Matsumura","year":"2018","journal-title":"Org. Lett."},{"issue":"11","key":"10.1016\/j.bioorg.2023.106600_b0700","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.3390\/ijms19113466","article-title":"The roles of autophagy in cancer","volume":"19","author":"Yun","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2023.106600_b0705","doi-asserted-by":"crossref","first-page":"7814","DOI":"10.1021\/acs.jmedchem.8b00790","article-title":"Total synthesis and structure-activity relationships study of odilorhabdins, a new class of peptides showing potent antibacterial activity","volume":"61","author":"Sarciaux","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0710","unstructured":"A.D. Chakrabarti, I.D. Chakrabarti, Anti-Malarial Compounds from Marine Natural Products, 2015."},{"key":"10.1016\/j.bioorg.2023.106600_b0715","unstructured":"M. Arai, Azalomycins B and F, two new antibiotics. I. Production and isolation, J. Antibiot. Ser. A. 13 (1960) 46\u201350."},{"key":"10.1016\/j.bioorg.2023.106600_b0720","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7164\/antibiotics.21.83","article-title":"Effect of azalomycin f on bacteria","volume":"21","author":"Sugawara","year":"1968","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.bioorg.2023.106600_b0725","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/mrc.2697","article-title":"1H and 13C assignments of two new macrocyclic lactones isolated from Streptomyces sp. 211726 and revised assignments of Azalomycins F3a, F4aand F5a","volume":"49","author":"Yuan","year":"2011","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0730","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3390\/md11030817","article-title":"New azalomycin F analogs from mangrove Streptomyces sp. 211726 with activity against microbes and cancer cells","volume":"11","author":"Yuan","year":"2013","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.bioorg.2023.106600_b0735","first-page":"309","article-title":"Anti-methicillin-resistant Staphylococcus aureus assay of azalomycin F5a and its derivatives, Chin","volume":"12","author":"Yuan","year":"2014","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.bioorg.2023.106600_b0740","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.biopha.2018.11.067","article-title":"Azalomycin F 5a, a polyhydroxy macrolide binding to the polar head of phospholipid and targeting to lipoteichoic acid to kill methicillin-resistant Staphylococcus aureus","volume":"109","author":"Yuan","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2023.106600_b0745","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature14098","article-title":"A new antibiotic kills pathogens without detectable resistance","volume":"517","author":"Ling","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2023.106600_b0750","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14787210.2019.1550357","article-title":"Teixobactin: a novel anti-infective agent","volume":"17","author":"McCarthy","year":"2019","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.bioorg.2023.106600_b0755","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11211-y","article-title":"Gram-scale total synthesis of teixobactin promoting binding mode study and discovery of more potent antibiotics","volume":"10","author":"Zong","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2023.106600_b0760","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1021\/acs.jnatprod.9b00932","article-title":"Structure, Biosynthesis, and Bioactivity of Photoditritide from Photorhabdus temperata Meg1","volume":"82","author":"Zhao","year":"2019","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2023.106600_b0765","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1021\/acs.jnatprod.7b00638","article-title":"Cybastacines A and B: antibiotic sesterterpenes from a Nostoc sp. Cyanobacterium","volume":"81","author":"Cabanillas","year":"2018","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2023.106600_b0770","doi-asserted-by":"crossref","first-page":"6531","DOI":"10.1016\/S0040-4039(00)97109-0","article-title":"Two new guanidine alkaloids from the mediterranean sponge crambe crambe","volume":"31","author":"Berlinck","year":"1990","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2023.106600_b0775","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1021\/np501052a","article-title":"Antipodal crambescin A2 homologues from the marine sponge pseudaxinella reticulate. Antifungal structure-activity relationships","volume":"78","author":"Jamison","year":"2015","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2023.106600_b0780","first-page":"33","article-title":"Antifungal activity of metabolites from the marine sponges Amphimedon sp. and Monanchora arbuscula against Aspergillus flavus strains isolated from peanuts (Arachis hypogaea)","volume":"9","author":"Arevabini","year":"2014","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.bioorg.2023.106600_b0785","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1021\/acs.jnatprod.5b00070","article-title":"Anti-parasitic guanidine and pyrimidine alkaloids from the marine sponge Monanchora arbuscula","volume":"78","author":"Santos","year":"2015","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2023.106600_b0790","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1021\/acs.jnatprod.6b01079","article-title":"Unguiculin A and ptilomycalins E-H, antimalarial guanidine alkaloids from the marine sponge Monanchora unguiculata","volume":"80","author":"Campos","year":"2017","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2023.106600_b0795","unstructured":"University of Alabama, A Phase I Study of ABT 510 for Newly Diagnosed Glioblastoma Multiforme, ClinicalTrials.Gov. (2019). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00584883?term=ABT-510&draw=2&rank=3."},{"key":"10.1016\/j.bioorg.2023.106600_b0800","unstructured":"ClinicalTrials.gov., ABT-510, ClinicalTrials.Gov. (2014). https:\/\/clinicaltrials.gov\/ct2\/results?recrs=&cond=&term=ABT-510&cntry=&state=&city=&dist=."},{"key":"10.1016\/j.bioorg.2023.106600_b0805","unstructured":"I. Spectrum Pharmaceuticals, International,Multi-Center,Open Label,Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot in Men With Prostate Cancer, ClinicalTrials.Gov. (2015). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01252693?term=Ozarelix&draw=2&rank=2."},{"key":"10.1016\/j.bioorg.2023.106600_b0810","unstructured":"Tarix Pharmaceuticals, Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myeloma Patients (TXA127-PBSC), ClinicalTrials.Gov. (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01121120?term=Angiotensin+1-7&draw=3&rank=13."},{"key":"10.1016\/j.bioorg.2023.106600_b0815","unstructured":"ClinicalTrials.gov., Brilacidin, ClinicalTrials.Gov. (2021). https:\/\/clinicaltrials.gov\/ct2\/results?cond=&term=brilacidin&cntry=&state=&city=&dist=."},{"key":"10.1016\/j.bioorg.2023.106600_b0820","unstructured":"Inc. (C.C.) Innovation Pharmaceuticals, Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections, ClinicalTrials.Gov. (2018). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02052388."},{"key":"10.1016\/j.bioorg.2023.106600_b0825","unstructured":"P. AS, LTX-109 as Treatment for Hidradenitis Suppurativa, ClinicalTrials.Gov. (2021). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04756336?term=LTX-109&draw=2&rank=2."},{"key":"10.1016\/j.bioorg.2023.106600_b0830","unstructured":"ClinicalTrials.gov., LTX-109, ClinicalTrials.Gov. (2021). https:\/\/clinicaltrials.gov\/ct2\/results?cond=&term=LTX-109&cntry=&state=&city=&dist=."},{"key":"10.1016\/j.bioorg.2023.106600_b0835","unstructured":"WHO, Coronavirus disease (COVID-19) pandemic, WHO Site. (2020). https:\/\/www.euro.who.int\/en\/health-topics\/health-emergencies\/coronavirus-covid-19\/novel-coronavirus-2019-ncov."},{"key":"10.1016\/j.bioorg.2023.106600_b0840","unstructured":"Innovation Pharmaceuticals, A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19, ClinicalTrials.Gov. (2021). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04784897?term=brilacidin&draw=2&rank=2."},{"key":"10.1016\/j.bioorg.2023.106600_b0845","unstructured":"P.H. SA, Study to Evaluate a Single Dose of LTX-109 in Subjects With COVID-19 (Coronavirus Disease 2019) Infection, ClinicalTrials.Gov. (2021). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04854928?term=LTX-109&draw=2&rank=1."},{"key":"10.1016\/j.bioorg.2023.106600_b0850","unstructured":"R.H. CareCampus, Angiotensin 1-7 as a Therapy in the Treatment of COVID-19, ClinicalTrials.Gov. (2021). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04605887?term=Angiotensin+1-7&draw=2&rank=1."},{"key":"10.1016\/j.bioorg.2023.106600_b0855","unstructured":"O.P.Co. Ltd, A Study of FOY-305 in Patients With SARS-Cov-2 Infection (COVID-19), ClinicalTrials.Gov. (2021). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04657497?term=Gabexate&draw=2&rank=3."},{"key":"10.1016\/j.bioorg.2023.106600_b0860","unstructured":"ClinicalTrials.gov., Camostat | COVID-19, ClinicalTrials.Gov. (2021)."},{"key":"10.1016\/j.bioorg.2023.106600_b0865","unstructured":"Imperial College London, RAS and Coagulopathy in COVID19, ClinicalTrials.Gov. (2021). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04419610?term=TRV-120027&draw=2&rank=4."},{"key":"10.1016\/j.bioorg.2023.106600_b0870","unstructured":"Gyeongsang National University Hospital, Clinical Efficacy of Nafamostat Mesylate for COVID-19 Pneumonia, ClinicalTrials.Gov. (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04418128?term=Nafamostat&draw=2&rank=1."},{"key":"10.1016\/j.bioorg.2023.106600_b0875","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1039\/C8MD00425K","article-title":"Recent developments in compounds acting in the DNA minor groove","volume":"10","author":"Rahman","year":"2019","journal-title":"MedChemComm"},{"key":"10.1016\/j.bioorg.2023.106600_b0880","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1021\/acs.jmedchem.8b00233","article-title":"Thermodynamics of DNA minor groove binders","volume":"62","author":"Alniss","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106600_b0885","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.parint.2012.05.015","article-title":"Nuclease activity and ultrastructural effects of new sulfonamides with anti-leishmanial and trypanocidal activities","volume":"61","author":"Bilbao-Ramos","year":"2012","journal-title":"Parasitol. Int."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823002614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823002614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:47:10Z","timestamp":1758617230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206823002614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":177,"alternative-id":["S0045206823002614"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106600","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetic and natural guanidine derivatives as antitumor and antimicrobial agents: A review","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106600","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106600"}}